Delivery Order SPE2DR25D3401-SPE2DR26FL0CB
- Not listed
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a ceiling value of $3,434.34. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and represents a non-competitive set-aside transaction. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a delivery order valued at $2,192.78 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,113.37 for Mounjaro 2.5 mg/0.5 mL pen injectables, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $5,764.40, with completion expected by November 21, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $5,694.15 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of October 23, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the nation's leading pharmaceutical distributor, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $2,533.44. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, supporting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,354.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $15,654.67 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pens. This competitively awarded, non-set-aside delivery order is a firm fixed price contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0CBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,107.36 for Mounjaro 15 mg/0.5 ml pens on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed price, non-set-aside delivery order represents a single pharmaceutical product procurement supporting military and federal healthcare supply needs. The award is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor with extensive experience fulfilling DLA requirements across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent competitively-awarded delivery orders with firm fixed pricing for medications including specialty drugs, generics, vaccines, and medical supplies. Mounjaro, a diabetes treatment medication, aligns with AmerisourceBergen's established role in supplying endocrinology and specialty pharmaceutical products to support Defense Health Agency and broader federal healthcare systems. Performance for this delivery order is specified at the contractor's Conshohocken, Pennsylvania location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/20/25 |